Skip to main content
OpenTrials

Clinical trial condition

Stomach Neoplasms

Explore clinical trials studying Stomach Neoplasms. Study availability and eligibility vary by location and protocol.

1,998 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Stomach Neoplasms trial results

Active, Not Recruiting

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

NCT04550494

Conditions
Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +64 more
Locations
  • UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
View Trial Details
Active, Not Recruiting

A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).

NCT03653507

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +13 more
Locations
  • Pacific Cancer Care Monterey, California, United States
  • University of Kansas Cancer Center and Medical Pavilion Fairway, Kansas, United States
  • Ochsner Clinic CCOP New Orleans, Louisiana, United States
  • New Mexico Oncology Hematology Albuquerque, New Mexico, United States
View all 165 locations
View Trial Details
Active, Not Recruiting

A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction

NCT04661150

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • West China Hospital, Sichuan University Chengdu, China
  • Nanfang Hospital, Southern Medical University Guangzhou, China
  • Harbin Medical University Cancer Hospital Harbin, China
View Trial Details
Active, Not Recruiting

A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.

NCT02734004

Conditions
Adnexal Diseases, Breast, Breast Diseases, +34 more
Locations
  • Research Site Newnan, Georgia, United States
  • Research Site Towson, Maryland, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Detroit, Michigan, United States
View all 47 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines

NCT04535401

Conditions
Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma, Advanced Gastric Carcinoma, +24 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Siteman Cancer Center at Saint Peters Hospital City of Saint Peters, Missouri, United States
View Trial Details
Active, Not Recruiting

Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab

NCT04130516

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
View Trial Details
Active, Not Recruiting

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

NCT06346392

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations
  • Research Site Mobile, Alabama, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Irvine, California, United States
View all 158 locations
View Trial Details
Active, Not Recruiting

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

NCT06147037

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +42 more
Locations
  • Research Site Palo Alto, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Omaha, Nebraska, United States
  • Research Site Cleveland, Ohio, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation

NCT07023731

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +61 more
Locations
  • Clinical Trial Site Phoenix, Arizona, United States
  • Clinical Trial Site Phoenix, Arizona, United States
  • Clinical Trial Site New Haven, Connecticut, United States
  • Clinical Trial Site Tampa, Florida, United States
View all 14 locations
View Trial Details

Related conditions